8-KMaterial AgreementsFinancial Events

CARDINAL HEALTH INC 8-K Report, Material Agreement (Aug 10, 2006)

Filed August 10, 2006For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) announced the initiation of a new commercial paper program on August 9, 2006, allowing for the issuance of short-term unsecured notes up to an aggregate amount of $1.0 billion. These notes will have maturities not exceeding 364 days from issuance. The company anticipates this program will enable it to secure more favorable short-term borrowing rates. In conjunction with this new program, Cardinal Health also terminated its existing commercial paper dealer agreements with Banc of America, Credit Suisse First Boston, J.P. Morgan, and Barclays Capital Inc., effective August 10, 2006, without incurring any penalties. This strategic move suggests a refinancing or optimization of its short-term debt facilities to potentially reduce borrowing costs and streamline its financial operations.

Key Highlights

  • 1Cardinal Health established a new commercial paper program with a maximum aggregate issuance of $1.0 billion.
  • 2The program allows for the issuance of short-term unsecured notes with maturities of up to 364 days.
  • 3The company expects the new program to provide access to more favorable short-term borrowing rates.
  • 4Existing commercial paper dealer agreements with Banc of America, Credit Suisse First Boston, J.P. Morgan, and Barclays Capital Inc. were terminated.
  • 5The termination of previous agreements is effective August 10, 2006, and incurs no penalties.
  • 6The Bank of New York will serve as the Issuing and Paying Agent.
  • 7J.P. Morgan Securities Inc., Banc of America Securities LLC, Wachovia Capital Markets, LLC, and Goldman, Sachs & Co. will act as Dealers for the new program.

Frequently Asked Questions

The new commercial paper program is designed to allow Cardinal Health to issue short-term unsecured notes, up to $1.0 billion, with the expectation of obtaining more favorable short-term borrowing rates compared to existing arrangements.

The termination of previous commercial paper dealer agreements appears to be a strategic decision to streamline and potentially optimize its short-term financing by consolidating dealer relationships under the new program.

This announcement suggests Cardinal Health is proactively managing its short-term debt to potentially lower borrowing costs, which could have a positive impact on its interest expense and overall profitability. The ability to access $1.0 billion in short-term funding also indicates financial flexibility.

As the program involves unsecured notes, the primary risk relates to the company's creditworthiness. However, the maturities are short-term (up to 364 days), which generally mitigates some of the longer-term interest rate and credit risks associated with debt financing.